Skip to main content

Table 1 Demographics and clinical characteristics of patients with sepsis

From: Trends in the incidence and outcome of sepsis using data from a Japanese nationwide medical claims database-the Japan Sepsis Alliance (JaSA) study group-

Screened total inpatients, n

50,490,128

Extracted sepsis, n

2,043,073

Community-onset sepsis, n (%)

1,433,603 (70.2)

Age, year a

76 (66–84)

Female, n (%)

884,831 (41.4)

Comorbidity

 

 Malignant tumor, n (%)

712,219 (34.9)

 Hypertension, n (%)

537,818 (26.3)

 Diabetes mellitus, n (%)

445,438 (21.8)

 Heart failure, n (%)

376,676 (18.4)

 Cerebrovascular disease, n (%)

292,637 (14.3)

 Ischemic heart disease, n (%)

215,868 (10.6)

 Chronic respiratory disease, n (%)

179,898 (8.8)

 Chronic renal failure, n (%)

79,362 (3.9)

Focus of infection (n = 1,275,988)

 

 Respiratory, n (%)

523,057 (41.0)

 Urogenital, n (%)

194,799 (15.3)

 Abdominal, n (%)

147,409 (11.6)

 Bone and soft tissue, n (%)

70,577 (5.5)

 Meninges/brain/spinal cord, n (%)

25,984 (2.0)

 Heart, n (%)

12,139 (1.0)

 Sexually transmitted disease, n (%)

3719 (0.3)

 Blood, n (%)

3560 (0.3)

 Unknown, n (%)

294,745 (23.0)

The hospital day of the blood culture draw, day a

1 (1–2)

Length of antibiotic treatment, days

 

 Mean (SD)

18.7 (21.4)

 Median (IQR)

12 (8–21)

Length of hospital stay, days

 

 Mean (SD)

45.7 (104.9)

 Median (IQR)

29 (16–55)

ICU admission, n (%)

350,365 (17.1)

Length of ICU stay, days

 

 Mean (SD)

6.9 (6.2)

 Median (IQR)

5 (2–11)

In-hospital mortality, n (%) b

363,363 (20.1)

  1. ICU intensive care unit, SD standard deviation, IQR interquartile range
  2. aThe data shown represent the median value along with the interquartile range
  3. bAfter excluding repeat hospitalizations, total number of patients with sepsis was 1,808,113